Differential mechanisms of ang (1-7)-mediated vasodepressor effect in adult and aged candesartan-treated rats

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Bosnyak, S ^a   Widdop, R E ^a   Denton, K M ^a   Jones, E S ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; CANDESARTAN;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; HORMONE ACTION; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RAT; UPREGULATION; VASODEPRESSOR EFFECT;

EID: 84868282338     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/192567     Document Type: Article

References (34)

1. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., Breitbart R. E., Acton S., A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 19. Circulation Research 2000 87 5 E1 E9 2-s2.0-0038053724
2. Tipnis S. R., Hooper N. M., Hyde R., Karran E., Christie G., Turner A. J., A human homolog of angiotensin-converting enzymecloning and functional expression as a captopril-insensitive carboxypeptidase. Journal of Biological Chemistry 2000 275 43 33238 33243 2-s2.0-0034721906 10.1074/jbc.M002615200
3. Trask A. J., Ferrario C. M., Angiotensin-(17): pharmacology and new perspectives in cardiovascular treatments. Cardiovascular Drug Reviews 2007 25 2 162 174 2-s2.0-34447120723 10.1111/j.1527-3466.2007.00012.x (Pubitemid 47035429)
4. Rice G. I., Thomas D. A., Grant P. J., Turner A. J., Hooper N. M., Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochemical Journal 2004 383 1 45 51 2-s2.0-6344246036 10.1042/BJ20040634 (Pubitemid 39389449)
5. Santos R. A. S., Ferreira A. J., Angiotensin-(17) and the renin-angiotensin system. Current Opinion in Nephrology & Hypertension 2007 16 2 122 128 2-s2.0-33846957750 10.1097/MNH.0b013e328031f362
6. Santos R. A. S., Campagnole-Santos M. J., Baracho N. C. V., Fontes M. A. P., Silva L. C. S., Neves L. A. A., Oliveira D. R., Caligiorne S. M., Rodrigues A. R. V., Gropen C., Carvalho W. S., Silva A. C. S. E., Khosla M. C., Characterization of a new angiotensin antagonist selective for angiotensin-(17): evidence that the actions of angiotensin-(17) are mediated by specific angiotensin receptors. Brain Research Bulletin 1994 35 4 293 298 2-s2.0-0028061656 10.1016/0361-9230(94)90104-X (Pubitemid 24332669)
7. Santos R. A. S., Simoes e Silva A. C., Maric C., Silva D. M. R., Machado R. P., De Buhr I., Heringer-Walther S., Pinheiro S. V. B., Lopes M. T., Bader M., Mendes E. P., Lemos V. S., Campagnole-Santos M. J., Schultheiss H. P., Speth R., Walther T., Angiotensin-(17) is an endogenous ligand for the G protein-coupled receptor Mas. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8258 8263 2-s2.0-0037478671 10.1073/pnas.1432869100 (Pubitemid 36842532)
8. De Castro C. H., Santos R. A. S., Ferreira A. J., Bader M., Alenina N., Almeida A. P., Evidence for a functional interaction of the angiotensin-(17) receptor Mas with AT(1) and AT(2) receptors in the mouse heart. Hypertension 2005 46 4 937 942 2-s2.0-33644653008
9. De Souza A. M., Lopes A. G., Pizzino C. P., Fossari R. N., Miguel N. C. O., Cardozo F. P., Abi-Abib R., Fernandes M. S., Santos D. P. A., Caruso-Neves C., Angiotensin II and angiotensin-(17) inhibit the inner cortex Na +-ATPase activity through AT(2) receptor. Regulatory Peptides 2004 120 13 167 175 2-s2.0-2642575690 10.1016/j.regpep.2004.03.005 (Pubitemid 38726206)
10. Lara L. D. S., Cavalcante F., Axelband F. O., De Souza A. M., Lopes A. G., Caruso-Neves C., Involvement of the Gi/o/cGMP/PKG pathway in the AT 2-mediated inhibition of outer cortex proximal tubule Na +-ATPase by Ang-(17). Biochemical Journal 2006 395 1 183 190 2-s2.0-33645567434 10.1042/BJ20051455
11. Walters P. E., Gaspari T. A., Widdop R. E., Angiotensin-(17) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension 2005 45 5 960 966 2-s2.0-18244391184 10.1161/01.HYP.0000160325. 59323.b8 (Pubitemid 40628944)
12. Barber M. N., Sampey D. B., Widdop R. E., AT2 receptor stimulation enhances antihypertensive effect of AT1 receptor antagonist in hypertensive rats. Hypertension 1999 34 5 1112 1116 2-s2.0-0032733920
13. Li X. C., Widdop R. E., AT2 receptor-mediated vasodilatation is unmasked by AT 1 receptor blockade in conscious SHR. The British Journal of Pharmacology 2004 142 5 821 830 2-s2.0-3242892150 10.1038/sj.bjp.0705838 (Pubitemid 38998096)
14. Bosnyak S., Welungoda I. K., Hallberg A., Alterman M., Widdop R. E., Jones E. S., Stimulation of angiotensin AT(2) receptors by the non-peptide agonist, Compound 21, evokes vasodepressor effects in conscious spontaneously hypertensive rats. The British Journal of Pharmacology 2010 159 3 709 716 2-s2.0-76449117787 10.1111/j.1476-5381.2009.00575.x
15. Wang M., Takagi G., Asai K., Resuello R. G., Natividad F. F., Vatner D. E., Vatner S. F., Lakatta E. G., Aging increases aortic MMP-2 activity and angiotensin II in nonhuman primates. Hypertension 2003 41 6 1308 1316 2-s2.0-0038119606 10.1161/01.HYP.0000073843.56046.45 (Pubitemid 36706082)
16. Widdop R. E., Vinh A., Henrion D., Jones E. S., Vascular angiotensin AT2 receptors in hypertension and ageing. Clinical and Experimental Pharmacology and Physiology 2008 35 4 386 390 2-s2.0-40349103781 10.1111/j.1440-1681.2008.04883. x (Pubitemid 351337334)
17. Dimitropoulou C., White R. E., Fuchs L., Zhang H., Catravas J. D., Carrier G. O., Angiotensin II relaxes microvessels via the AT(2) receptor and Ca2+-activated K+ (BKCa) channels. Hypertension 2001 37 2 I 301 307 2-s2.0-0035091037 (Pubitemid 32199091)
18. Matrougui K., Levy B. I., Henrion D., Tissue angiotensin II and endothelin-1 modulate differently the response to flow in mesenteric resistance arteries of normotensive and spontaneously hypertensive rats. The British Journal of Pharmacology 2000 130 3 521 526 2-s2.0-0034068489 (Pubitemid 30332969)
19. Matrougui K., Loufrani L., Heymes C., Lévy B. I., Henrion D., Activation of AT2 receptors by endogenous angiotensin II is involved in flow-induced dilation in rat resistance arteries. Hypertension 1999 34 4 I 659 665 2-s2.0-0032728585 (Pubitemid 29496450)
20. Widdop R. E., Matrougui K., Levy B. I., Henrion D., AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension 2002 40 4 516 520 2-s2.0-0036771844 10.1161/01.HYP.0000033224.99806.8A
21. Henrion D., Kubis N., Lévy B. I., Physiological and pathophysiological functions of the AT2 subtype receptor of angiotensin II from large arteries to the microcirculation. Hypertension 2001 38 5 1150 1157 2-s2.0-0035725997 (Pubitemid 34252821)
22. Carey R. M., Howell N. L., Jin X. H., Siragy H. M., Angiotensin type 2 receptor-mediated hypotension in angiotensin type-1 receptor-blocked rats. Hypertension 2001 38 6 1272 1277 2-s2.0-0035672001 (Pubitemid 34033401)
23. Widdop R. E., Jones E. S., Hannan R. E., Gaspari T. A., Angiotensin AT2 receptors: cardiovascular hope or hype? The British Journal of Pharmacology 2003 140 5 809 824 2-s2.0-0345304290 10.1038/sj.bjp.0705448 (Pubitemid 37464062)
24. Jones E. S., Black M. J., Widdop R. E., Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade. Journal of Molecular and Cellular Cardiology 2004 37 5 1023 1030 2-s2.0-7444272132 10.1016/j.yjmcc.2004.08.004 (Pubitemid 39446827)
25. Pinaud F., Bocquet A., Dumont O., Retailleau K., Baufreton C., Andriantsitohaina R., Loufrani L., Henrion D., Paradoxical role of angiotensin II type 2 receptors in resistance arteries of old rats. Hypertension 2007 50 1 96 102 2-s2.0-34250796304 10.1161/HYPERTENSIONAHA.106.085035 (Pubitemid 46986016)
26. Peiro C., Vallejo S., Gembardt F., Azcutia V., Heringer-Walther S., Rodríguez-Mañas L., Schultheiss H. P., Sánchez-Ferrer C. F., Walther T., Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function. J. Hypertenss 2007 25 12 2421 2425 (Pubitemid 350060381)
27. Gorelik G., Carbini L. A., Scicli A. G., Angiotensin 17 induces bradykinin-mediated relaxation in porcine coronary artery. Journal of Pharmacology and Experimental Therapeutics 1998 286 1 403 410 2-s2.0-0031848366 (Pubitemid 28318016)
28. Wiemer G., Dobrucki L. W., Louka F. R., Malinski T., Heitsch H., AVE 0991, a nonpeptide mimic of the effects of angiotensin-(17) on the endothelium. Hypertension 2002 40 6 847 852 2-s2.0-0036900194 10.1161/01.HYP.0000037979. 53963.8F (Pubitemid 35434905)
29. Heitsch H., Brovkovych S., Malinski T., Wiemer G., Angiotensin-(17)- stimulated nitric oxide and superoxide release from endothelial cells. Hypertension 2001 37 1 72 76 2-s2.0-0035154879 (Pubitemid 32064242)
30. Muthalif M. M., Benter I. F., Uddin M. R., Harper J. L., Malik K. U., Signal transduction mechanisms involved in angiotensin-(17)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells. Journal of Pharmacology and Experimental Therapeutics 1998 284 1 388 398 2-s2.0-0031912569 (Pubitemid 28109570)
31. Tesanovic S., Vinh A., Gaspari T. A., Casley D., Widdop R. E., Vasoprotective and atheroprotective effects of angiotensin (17) in apolipoprotein E-deficient mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2010 30 8 1606 1613 2-s2.0-77955175630 10.1161/ATVBAHA.110.204453
32. Hannan R. E., Davis E. A., Widdop R. E., Functional role of angiotensin II AT(2) receptor in modulation of AT(1) receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide. The British Journal of Pharmacology 2003 140 5 987 995 2-s2.0-0345538680 10.1038/sj.bjp.0705484 (Pubitemid 37464083)
33. Zwart A. S., Davis E. A., Widdop R. E., Modulation of AT1 receptor-mediated contraction of rat uterine artery by AT(2) receptors. The British Journal of Pharmacology 1998 125 7 1429 1436 2-s2.0-0031593617 (Pubitemid 28548554)
34. Batenburg W. W., Garrelds I. M., Bernasconi C. C., Juillerat-Jeanneret L., Van Kats J. P., Saxena P. R., Danser A. H. J., Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries. Circulation 2004 109 19 2296 2301 2-s2.0-2442687960 10.1161/01.CIR.0000128696.12245.57 (Pubitemid 38656868)